Literature DB >> 27688479

18F-FDG PET in Posterior Cortical Atrophy and Dementia with Lewy Bodies.

Jennifer L Whitwell1, Jonathan Graff-Radford2, Tarun D Singh2, Daniel A Drubach2, Matthew L Senjem3,4, Anthony J Spychalla3, Nirubol Tosakulwong5, Val J Lowe3, Keith A Josephs2.   

Abstract

Posterior cortical atrophy (PCA) and dementia with Lewy bodies (DLB) have both been associated with occipital lobe hypometabolism on 18F-FDG PET, whereas relative sparing of posterior cingulate metabolism compared with precuneus/cuneus (i.e., cingulate island sign) is a feature of DLB. We aimed to determine whether patterns of hypometabolism or the cingulate island sign differed between PCA and DLB.
Methods: Sixteen clinically diagnosed PCA and 13 probable DLB subjects underwent 18F-FDG PET. All PCA subjects showed β-amyloid deposition on PET scanning. Regional hypometabolism was assessed compared with a control cohort (n = 29) using voxel- and region-level analyses in statistical parametric mapping. A ratio of metabolism in the posterior cingulate to precuneus plus cuneus was calculated to assess the cingulate island sign. In addition, the 18F-FDG PET scans were visually assessed to determine whether the cingulate island sign was present in each subject.
Results: PCA and DLB showed overlapping patterns of hypometabolism involving the lateral occipital lobe, lingual gyrus, cuneus, precuneus, posterior cingulate, inferior parietal lobe, supramarginal gyrus, striatum, and thalamus. However, DLB showed greater hypometabolism in the medial occipital lobe, orbitofrontal cortex, anterior temporal lobe, and caudate nucleus than PCA, and PCA showed more asymmetric patterns of hypometabolism than DLB. The cingulate island sign was present in both DLB and PCA, although it was more asymmetric in PCA.
Conclusion: Regional hypometabolism overlaps to a large degree between PCA and DLB, although the degree of involvement of the frontal and anterior temporal lobes and the presence of asymmetry could be useful in differential diagnosis.
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  18F-FDG PET; cingulate island sign; dementia with Lewy bodies; posterior cortical atrophy

Mesh:

Substances:

Year:  2016        PMID: 27688479      PMCID: PMC5373504          DOI: 10.2967/jnumed.116.179903

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  38 in total

1.  Posterior cortical atrophy: variant of Alzheimer's disease? A case series with PET findings.

Authors:  Klaus Schmidtke; Michael Hüll; Jochen Talazko
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

2.  Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation.

Authors:  S Minoshima; N L Foster; A A Sima; K A Frey; R L Albin; D E Kuhl
Journal:  Ann Neurol       Date:  2001-09       Impact factor: 10.422

3.  Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease.

Authors:  R L Albin; S Minoshima; C J D'Amato; K A Frey; D A Kuhl; A A Sima
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

4.  Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.

Authors:  Jennifer L Whitwell; Stephen D Weigand; Maria M Shiung; Bradley F Boeve; Tanis J Ferman; Glenn E Smith; David S Knopman; Ronald C Petersen; Eduardo E Benarroch; Keith A Josephs; Clifford R Jack
Journal:  Brain       Date:  2007-01-31       Impact factor: 13.501

5.  Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.

Authors:  Sid Gilman; Robert A Koeppe; Roderick Little; Hyonggin An; Larry Junck; Bruno Giordani; Carol Persad; Mary Heumann; Kris Wernette
Journal:  Exp Neurol       Date:  2005-02       Impact factor: 5.330

6.  Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution.

Authors:  M H Rosenbloom; A Alkalay; N Agarwal; S L Baker; J P O'Neil; M Janabi; I V Yen; M Growdon; J Jang; C Madison; E C Mormino; H J Rosen; M L Gorno-Tempini; M W Weiner; B L Miller; W J Jagust; G D Rabinovici
Journal:  Neurology       Date:  2011-04-27       Impact factor: 9.910

7.  Cingulate island sign on FDG-PET is associated with medial temporal lobe atrophy in dementia with Lewy bodies.

Authors:  Tomomichi Iizuka; Masashi Kameyama
Journal:  Ann Nucl Med       Date:  2016-04-20       Impact factor: 2.668

8.  Cerebral metabolic dysfunction in patients with dementia with Lewy bodies and visual hallucinations.

Authors:  Robert Perneczky; Alexander Drzezga; Henning Boecker; Hans Förstl; Alexander Kurz; Peter Häussermann
Journal:  Dement Geriatr Cogn Disord       Date:  2008-05-14       Impact factor: 2.959

9.  The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET.

Authors:  P J Nestor; D Caine; T D Fryer; J Clarke; J R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

10.  Motor features in posterior cortical atrophy and their imaging correlates.

Authors:  Natalie S Ryan; Timothy J Shakespeare; Manja Lehmann; Shiva Keihaninejad; Jennifer M Nicholas; Kelvin K Leung; Nick C Fox; Sebastian J Crutch
Journal:  Neurobiol Aging       Date:  2014-06-06       Impact factor: 4.673

View more
  26 in total

Review 1.  Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Kirk A Frey
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-14       Impact factor: 5.081

Review 2.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

3.  [18 F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease.

Authors:  Jennifer L Whitwell; Jonathan Graff-Radford; Nirubol Tosakulwong; Stephen D Weigand; Mary Machulda; Matthew L Senjem; Christopher G Schwarz; Anthony J Spychalla; David T Jones; Daniel A Drubach; David S Knopman; Bradley F Boeve; Nilüfer Ertekin-Taner; Ronald C Petersen; Val J Lowe; Clifford R Jack; Keith A Josephs
Journal:  Ann Neurol       Date:  2018-02-06       Impact factor: 10.422

4.  Brain metabolic signatures across the Alzheimer's disease spectrum.

Authors:  Arianna Sala; Camilla Caprioglio; Roberto Santangelo; Emilia Giovanna Vanoli; Sandro Iannaccone; Giuseppe Magnani; Daniela Perani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-07       Impact factor: 9.236

Review 5.  Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction.

Authors:  Marco Onofrj; Alberto J Espay; Laura Bonanni; Stefano Delli Pizzi; Stefano L Sensi
Journal:  Mov Disord       Date:  2019-07-15       Impact factor: 10.338

6.  Dementia with Lewy bodies presenting as Logopenic variant primary progressive Aphasia.

Authors:  Samuel Boes; Hugo Botha; Mary Machulda; Val Lowe; Jonathan Graff-Radford; Jennifer L Whitwell; Rene L Utianski; Joseph R Duffy; Keith A Josephs
Journal:  Neurocase       Date:  2020-07-16       Impact factor: 0.881

7.  Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease.

Authors:  Jennifer L Whitwell; Jonathan Graff-Radford; Nirubol Tosakulwong; Stephen D Weigand; Mary M Machulda; Matthew L Senjem; Anthony J Spychalla; Prashanthi Vemuri; David T Jones; Daniel A Drubach; David S Knopman; Bradley F Boeve; Nilüfer Ertekin-Taner; Ronald C Petersen; Val J Lowe; Clifford R Jack; Keith A Josephs
Journal:  Alzheimers Dement       Date:  2018-03-30       Impact factor: 21.566

8.  Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.

Authors:  Katerina A Tetzloff; Jonathan Graff-Radford; Peter R Martin; Nirubol Tosakulwong; Mary M Machulda; Joseph R Duffy; Heather M Clark; Matthew L Senjem; Christopher G Schwarz; Anthony J Spychalla; Daniel A Drubach; Clifford R Jack; Val J Lowe; Keith A Josephs; Jennifer L Whitwell
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 9.  Neuroradiology for ophthalmologists.

Authors:  Bayan Al Othman; Jared Raabe; Ashwini Kini; Andrew G Lee
Journal:  Eye (Lond)       Date:  2020-01-02       Impact factor: 3.775

Review 10.  New insights into atypical Alzheimer's disease in the era of biomarkers.

Authors:  Jonathan Graff-Radford; Keir X X Yong; Liana G Apostolova; Femke H Bouwman; Maria Carrillo; Bradford C Dickerson; Gil D Rabinovici; Jonathan M Schott; David T Jones; Melissa E Murray
Journal:  Lancet Neurol       Date:  2021-03       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.